Literature DB >> 2156160

Neurofibromatous neuropathy.

P K Thomas1, R H King, T R Chiang, F Scaravilli, A K Sharma, A W Downie.   

Abstract

Three cases of chronic distal sensorimotor neuropathy are described in patients with neurofibromatosis. One had type 2 or central neurofibromatosis with a chromosome 22 deletion; the precise form of the disease was not established in the other two. A striking clinical feature was a diffuse nodular enlargement of the peripheral nerves. Nerve biopsies from all three cases demonstrated the presence of neurofibromatous pathology. Neurofibromatous neuropathy constitutes a rare manifestation of neurofibromatosis, related to diffuse neurofibromatous changes in the peripheral nerves.

Entities:  

Mesh:

Year:  1990        PMID: 2156160     DOI: 10.1002/mus.880130202

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  11 in total

1.  Nerve root and sciatic trunk enlargement in Déjérine-Sottas disease: MRI appearances.

Authors:  N Masuda; H Hayashi; H Tanabe
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

Review 2.  Neurofibromatosis type 2.

Authors:  Ashok R Asthagiri; Dilys M Parry; John A Butman; H Jeffrey Kim; Ekaterini T Tsilou; Zhengping Zhuang; Russell R Lonser
Journal:  Lancet       Date:  2009-05-22       Impact factor: 79.321

3.  Neurofibromatosis type 2 in an adolescent boy with polyneuropathy and a mutation in the NF2 gene.

Authors:  W C Overweg-Plandsoen; R Brouwer-Mladin; P Merel; L de Vries; E K Bijlsma
Journal:  J Neurol       Date:  1996-10       Impact factor: 4.849

Review 4.  Neurofibromatosis type 2.

Authors:  D G Evans; M Sainio; M E Baser
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

5.  Familial spinal neurofibromatosis due to a multiexonic NF1 gene deletion.

Authors:  Antonio Pizzuti; Irene Bottillo; Francesca Inzana; Valentina Lanari; Francesca Buttarelli; Isabella Torrente; Anna Teresa Giallonardo; Alessandro De Luca; Bruno Dallapiccola
Journal:  Neurogenetics       Date:  2011-03-02       Impact factor: 2.660

Review 6.  Emerging therapeutic targets for neurofibromatosis type 1.

Authors:  James A Walker; Meena Upadhyaya
Journal:  Expert Opin Ther Targets       Date:  2018-05-07       Impact factor: 6.902

7.  Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.

Authors:  D M Parry; M M MacCollin; M I Kaiser-Kupfer; K Pulaski; H S Nicholson; M Bolesta; R Eldridge; J F Gusella
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

8.  Accumulation of non-compressive fascicular lesions underlies NF2 polyneuropathy.

Authors:  P Bäumer; V F Mautner; T Bäumer; M U Schuhmann; M Tatagiba; S Heiland; T Kaestel; M Bendszus; M Pham
Journal:  J Neurol       Date:  2012-07-04       Impact factor: 4.849

9.  A case of neurofibromatosis 2 presenting with a mononeuritis multiplex.

Authors:  T J Kilpatrick; R J Hjorth; M F Gonzales
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-05       Impact factor: 10.154

10.  A patient with neurofibromatosis type 1 and Charcot-Marie-Tooth disease type 1B.

Authors:  Eric Lancaster; Lauren B Elman; Steven S Scherer
Journal:  Muscle Nerve       Date:  2010-04       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.